Advanced glycation endproducts induce self- and cross-tolerance in monocytes

Introduction Advanced glycation endproducts (AGEs) are well-known inflammatory mediators, which are recognized by immune cells through their corresponding receptor RAGE and have been shown to participate in the pathophysiology of a variety of acute as well as chronic inflammatory diseases. Neverthel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Inflammation research 2017-11, Vol.66 (11), p.961-968
Hauptverfasser:	Uhle, Florian, Weiterer, Sebastian, Siegler, Benedikt Hermann, Brenner, Thorsten, Lichtenstern, Christoph, Weigand, Markus Alexander
Format:	Artikel
Sprache:	eng
Schlagworte:	Advanced glycosylation end products Age Allergology Biomedical and Life Sciences Biomedicine Cell Cycle - drug effects Cell Line Cells, Cultured Cross-tolerance Cytometry Dermatology Enzyme-linked immunosorbent assay Flow cytometry Gene expression Gene flow Glycation End Products, Advanced - pharmacology Glycosylation Humans Immune system Immune Tolerance - drug effects Immunological tolerance Immunology Inflammatory diseases Intracellular Intracellular levels Lipopolysaccharides - pharmacology Monocytes Monocytes - drug effects Monocytes - metabolism Neurology Original Research Paper Pharmacology/Toxicology Post-transcription Receptors Rheumatology Sepsis Stimulation TLR4 protein Toll-like receptors Tumor necrosis factor Tumor Necrosis Factor-alpha - genetics Tumor Necrosis Factor-alpha - metabolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!